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Figure (1) 5123 voxel image with 45 projections and Poisson 
noise, (a) original (b) reconstruction using FDK, (c) 
reconstruction using SART. 
 
In terms of speedup, a CPU projection takes 24s on average 
in an Intel Core i7-4930K with 32Gb of RAM while a GPU 
projection takes 137ms in high accuracy settings and 17ms 
with the same accuracy in a NVIDIA Tesla k40c, resulting on a 
speedup of 175% and 1400% respectively.   
Figure 2 shows speed results for a single forward projection 
of a single angle in both low and high accuracy settings for 
different detector and image sizes, in logarithmic scale. It is 
easy to see in the figure that the algorithm is O(n3) for the 
image size and O(n2) for the detector size. Note that in the 
biggest image sizes memory bandwidth is a relevant factor in 
the time, as the image size in memory gets over 8Gb. Times 
for backprojection are always around 10% of the times for 
forward projection. 
 
 
 
Figure (2) Time for a single projection in the GPU, compared 
against the number of voxels and the number of detector 
pixels, for different accuracy levels, (a) 1 sample per voxel 
(as in matrix based methods), (b) 10 samples per voxel. 
Conclusions: The GPU based code speeds up the image 
reconstruction to over 3 orders of magnitude than CPU based 
algorithms, allowing the use of iterative reconstruction 
methods in clinically reasonable time scales. The future work 
involves modifying the algorithm for motion correction using 
the concepts from phase space tomography at CERN[3]. 
Additionally, an EIT based real-time motion detection will be 
used to better estimate patient motion, which can then be 
fed into CBCT reconstruction algorithm allowing for a dual 
modality based 4D CBCT. 
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The Center for Proton Therapy at PSI has been the worldwide 
pioneer of pencil beam scanned (PBS) proton therapy. 
Clinical operation started in 1996 on Gantry1, with Intensity 
Modulated Proton Therapy already being delivered clinically 
in 1999. Currently the facility is composed of two gantries 
and one horizontal beam line for ocular therapy. Gantry2, 
clinically operational since 2013, is a new generation proton 
PBS gantry, developed in-house at PSI, whilst Gantry3, 
currently in the technical commissioning phase, will be a 
ProBeam Gantry from Varian Medical System. First patient 
treatments on this facility will be at the end of 2016. 
Our future strategies are in a number of directions. First, we 
are working on significantly increasing the delivery speed of 
PBS treatments using continuous line scanning rather than 
discrete spots. This has already been demonstrated as a 
proof-of-principle on Gantry2, and the major work currently 
is on the development of fast beam monitoring, together 
with strategies for analyzing the resulting measured profiles.  
Second, the treatment of moving targets (4D) will be 
clinically implemented based on different motion mitigation 
techniques, including advanced rescanning, gating and 
continuous scanning. For the optimization of the 4D 
treatment delivery, different scanning techniques (i.e. 
volumetric and layered rescanning) have been evaluated and 
both will be implemented clinically. In order to calculate the 
dosimetric effect of the interplay between motion and 
scanning, our in house developed TPS system has been 
upgraded to include a fast and comprehensive 4D dose 
calculation option based on a deformable dose calculation 
grid, where the timing of the delivery parameters and the 
patient breathing (including variable breathing patterns) can 
be accurately taken into account.  
Our third aim is the clinical implementation of daily adaptive 
proton therapy, in order to more accurately take into 
account daily anatomical and positioning variations. As a CT-
on-rails scanner is installed in the Gantry2 bunker, 3D 
planning images can be acquired on a daily basis and used for 
a daily optimization of the plan before the daily delivery. In 
addition, on the ProBeam system, Cone-Beam CT acquisitions 
will be possible, allowing us to also investigate the usefulness 
of CBCT for daily adaptive approaches. In the daily 
optimization process, the cumulative dose delivered to the 
patient will be estimated using log-file based dose 
calculations as a type of ‘entrance-dosimetry’ which can 
reconstruct the actual delivered dose in the patient 
geometry of the day. This is based on machine log files, 
which are saved for each delivery, and which include all the 
machine parameters for the specific delivery (i.e. exact spot 
position, spot weight, MU per spot[1]). Finally, we are also 
investigating advanced uses of MRI imaging in proton therapy, 
for instance to monitor anatomical changes, organ motion 
and in-vivo range verification. 
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The finite range of a proton beam or heavier charged particle 
beam can be a double-edged sword. While it is the biggest 
physical/dosimetric advantage of particle beam therapy, the 
range over- or undershoot typically requires extra margins 
that can compromise the conformality of the dose 
distributions substantially. Recent developments aim at 
imaging the range of the particle beam in the patient, to (1) 
verify the range, and (2) potentially correct for any range 
discrepancies. We will review the state of the art of imaging 
for range assessment, focusing in particular on prompt 
gamma imaging.  
Significant progress has recently been made in the field of 
prompt gamma imaging.  Range errors of 1 mm are 
detectable in phantoms. Spectroscopic methods potentially 
allow one to obtain information about the elemental 
composition of the tissue. Commercial systems are under 
development and have recently been tested in the clinic. In 
addition to systems consisting of a detector-collimator 
combination, Compton cameras are under development for 
the 3D reconstruction of the prompt gamma sources. Prompt 
gamma imaging competes with other range imaging 
techniques such as PET imaging of oxygen-15 and carbon-11, 
and MRI imaging of the biological changes resulting from 
irradiating tissues. Another recent development is thermo-
acoustic imaging, utilizing the ultrasound signal that a high 
intensity particle beam produces in tissue due to quick 
thermal expansion. 
Once the particle range in the patient can be measured (a) in 
the patient,  (b) in realtime, (c) with millimeter accuracy, 
the range margins can be reduced, resulting in significant 
improvements of treatment quality for many disease sites. 
Unfortunately, none of the techniques developed so far fulfill 
all criteria (a,b,c) above. Millimeter accuracy is sometimes 
achievable but not in patients or not in all patients. Realtime 
measurement and control is only feasible with prompt 
gamma and thermo-acoustic imaging. Of the techniques 
currently under development, it appears that prompt gamma 
imaging has the best chance of fulfilling all the criteria above 
and becoming a valuable tool for particle range control in the 
clinic in the near future.  
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Aim: Protontherapy provided many evidences on the quality 
and accuracy in planning a treatment. Pencil-beam scanning 
technology with protons enables clinicians to precisely 
manipulate and direct the beam so that its energy conforms 
exactly to the unique size and shape of the tumor. This 
technique shows remarkable advantages in conforming the 
dose to the target.  
However, the main issue for many years has been the non-
accessible technology behind it. The huge expenses 
compared with conventional radiation therapy remain costs 
issues. 
Lowering costs providing a new solution for proton therapy 
facilities with active scanning technique is opening a new 
perspective in this field, allowing a larger use of proton 
beams. 
One of constraints that can drastically lower the costs is the 
use of a fixed source and not a grantry.  
Methods: The scope of this study is providing a full 
investigation from the positioning to the dose delivery to the 
patient, using an alternative position in system that 
reproduce configurations gantry-couch like, and propose 
additional not-standard configurations that help a better 
planning. 
A robot arm handling a couch offers an automated movement 
of the patient around the nozzle, providing more freedom 
and compensating the lack of gantry. The positioning system 
is controlled and interfaced with a dedicated software 
translating and converting complex motions to equivalent 
once in more standard positioning. 
Results: Full Monte Carlo investigations for plan with 
different setting are realized to check configurations of 
Nozzle-Robotic system and their impact on the treatment 
planning. It is possible then to see when we get advantages in 
combining such solutions. This is reached once we have a 
system well integrated within the the full workflow and the 
planning system. 
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Purpose: In medical applications, about 20 MeV and 100 μA 
proton beams are used for the production of PET 
radioisotopes. In hadrontherapy, energies of hundreds MeV 
per nucleon and intensities below 1 nA are employed. To 
monitor beams in this wide range of intensities with a single 
detector, the Universal BEam Monitoring detector (UniBEaM) 
based on doped silica and optical fibres was designed, built 
and tested. 
Materials and methods: The UniBEaM detector is based on a 
single doped silica fibre moved through the beam. The 
